• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 66 例甲状腺髓样癌患者的分子数据与组织病理学和临床特征的相关性分析。

Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.

机构信息

Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023, Lisboa, Portugal.

Serviço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 , Lisboa, Portugal.

出版信息

J Endocrinol Invest. 2021 Sep;44(9):1837-1846. doi: 10.1007/s40618-020-01456-6. Epub 2021 Feb 11.

DOI:10.1007/s40618-020-01456-6
PMID:33575974
Abstract

PURPOSE

Medullary thyroid carcinoma (MTC) displays a wide variety of histopathological features, and several histological variants have been described. In follicular cell-derived thyroid carcinomas, there is a good correlation between genotype and phenotype. In this study, we investigated whether such a correlation is also present in MTC.

METHODS

The histopathological features were evaluated in a series of 66 molecularly characterised tumours and correlated with the clinical characteristics.

RESULTS

Most MTC exhibited the classical variant (83.3%). Other variants included spindle cell (6.1%), pseudopapillary (4.5%), paraganglioma-like (3.0%), angiosarcoma-like (1.5%), and oncocytic follicular (1.5%). Tumours were classified into four groups: group 1, with somatic p.Met918Thr and p.Ala883Phe RET mutations; group 2, with other RET mutations; group 3, with RAS mutations; and group 4, without RET or RAS mutations. Tumours from groups 1 and 4 were typically associated with the classical variant, with abundant fibrosis, lymphovascular invasion, extrathyroidal extension, and more advanced stages of disease, whereas group 2 included histological variants other than the classical variant (namely, pseudopapillary and paraganglioma-like), with tumours that were highly cellular, less invasive, and with a better overall prognosis. In tumours from group 4, amyloid deposition was characteristically absent or low. The spindle cell variant appeared only in tumours from group 3, which had high cellularity and a degree of invasion and prognosis intermediate between groups 1 and 2, but better than group 4. The grade of fibrosis correlated directly with the clinical outcome.

CONCLUSION

Our results support the idea that a genotype-phenotype correlation does, indeed, exist in MTC. However, further studies are warranted to confirm these findings in a larger sample size.

摘要

目的

髓样甲状腺癌(MTC)表现出多种组织病理学特征,已经描述了几种组织学变体。在滤泡细胞来源的甲状腺癌中,基因型与表型之间存在良好的相关性。在这项研究中,我们研究了这种相关性是否也存在于 MTC 中。

方法

在一系列 66 个分子特征明确的肿瘤中评估了组织病理学特征,并将其与临床特征相关联。

结果

大多数 MTC 表现为经典变体(83.3%)。其他变体包括梭形细胞(6.1%)、假乳头(4.5%)、副神经节瘤样(3.0%)、血管肉瘤样(1.5%)和嗜酸细胞滤泡(1.5%)。肿瘤分为四组:组 1,体细胞 p.Met918Thr 和 p.Ala883Phe RET 突变;组 2,其他 RET 突变;组 3,RAS 突变;组 4,无 RET 或 RAS 突变。组 1 和 4 的肿瘤通常与经典变体相关,具有丰富的纤维化、血管淋巴管侵犯、甲状腺外延伸和更晚期的疾病阶段,而组 2 包括除经典变体以外的组织学变体(即假乳头和副神经节瘤样),肿瘤细胞丰富,侵袭性低,整体预后较好。在组 4 的肿瘤中,淀粉样物质沉积特征性地缺失或低。梭形细胞变体仅出现在组 3 的肿瘤中,其细胞性高,侵袭性和预后介于组 1 和 2 之间,但优于组 4。纤维化程度与临床结果直接相关。

结论

我们的结果支持 MTC 中确实存在基因型-表型相关性的观点。然而,需要进一步的研究来在更大的样本量中证实这些发现。

相似文献

1
Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.对 66 例甲状腺髓样癌患者的分子数据与组织病理学和临床特征的相关性分析。
J Endocrinol Invest. 2021 Sep;44(9):1837-1846. doi: 10.1007/s40618-020-01456-6. Epub 2021 Feb 11.
2
Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.19例降钙素无升高的甲状腺髓样癌临床及病理分析
Exp Toxicol Pathol. 2017 Oct 2;69(8):575-579. doi: 10.1016/j.etp.2017.05.003. Epub 2017 May 25.
3
Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.中国一位 RET M918T 种系突变的多发性内分泌腺瘤病 2B 相关混合性髓样和滤泡状甲状腺癌患者
Endocr Metab Immune Disord Drug Targets. 2021;21(3):554-560. doi: 10.2174/1871530320666200713092633.
4
Variability in Medullary Thyroid Carcinoma in L790F Carriers: A Case Comparison Study of Index Patients.L790F基因携带者的甲状腺髓样癌变异性:索引患者的病例对照研究
Front Endocrinol (Lausanne). 2020 Apr 28;11:251. doi: 10.3389/fendo.2020.00251. eCollection 2020.
5
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.国际多中心研究中髓样甲状腺癌基因组图谱与肿瘤特征和临床结局的关联。
Thyroid. 2024 Feb;34(2):167-176. doi: 10.1089/thy.2023.0279. Epub 2023 Nov 7.
6
Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.RET 原癌基因突变的多样性及其在甲状腺髓样癌中的致癌机制。
Crit Rev Clin Lab Sci. 2016 Aug;53(4):217-27. doi: 10.3109/10408363.2015.1129529. Epub 2016 Jan 27.
7
The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.甲状腺髓样癌中体细胞RAS突变的患病率——一项波兰人群研究
Endokrynol Pol. 2015;66(2):121-5. doi: 10.5603/EP.2015.0018.
8
Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.遗传性甲状腺髓样癌的基因型-表型相关性
Recent Results Cancer Res. 2015;204:139-56. doi: 10.1007/978-3-319-22542-5_6.
9
Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.多发性内分泌腺瘤2A型中的甲状腺髓样癌:美国甲状腺协会中度或高度风险的RET突变不能预测疾病侵袭性。
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2807-2813. doi: 10.1210/jc.2017-00317.
10
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.大样本甲状腺髓样癌中 RAS 突变低发生率的证据。
Thyroid. 2013 Jan;23(1):50-7. doi: 10.1089/thy.2012.0207. Epub 2012 Dec 16.

引用本文的文献

1
A Comparative Study on the Multidimensional Features of Hereditary and Sporadic Medullary Thyroid Carcinoma Patients: A Single-Center Retrospective Study.遗传性和散发性甲状腺髓样癌患者多维特征的比较研究:一项单中心回顾性研究
Medicina (Kaunas). 2025 Jun 27;61(7):1164. doi: 10.3390/medicina61071164.
2
Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer.国际甲状腺髓样癌分级系统的验证及EZH2作为甲状腺髓样癌预后和潜在治疗标志物的鉴定
Cancers (Basel). 2025 Feb 21;17(5):737. doi: 10.3390/cancers17050737.
3

本文引用的文献

1
Detection of Molecular Alterations in Taiwanese Patients with Medullary Thyroid Cancer Using Whole-Exome Sequencing.应用全外显子组测序检测台湾地区甲状腺髓样癌患者的分子改变。
Endocr Pathol. 2018 Dec;29(4):324-331. doi: 10.1007/s12022-018-9543-6.
2
Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis.散发性甲状腺髓样癌中 RET 和 RAS 突变的临床意义:一项荟萃分析。
Endocr Relat Cancer. 2018 Jun;25(6):633-641. doi: 10.1530/ERC-18-0056. Epub 2018 Apr 3.
3
Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.
Prognostic impact of fibrosclerotic changes in non-papillary, non-anaplastic, follicular cell-derived thyroid carcinomas.
非乳头状、非间变性、滤泡细胞源性甲状腺癌中纤维硬化性改变的预后影响
Virchows Arch. 2025 Jan 23. doi: 10.1007/s00428-025-04028-2.
4
ONCOCYTIC VARIANT OF MEDULLARY CARCINOMA THYROID - A RARE ENTITY.甲状腺髓样癌的嗜酸细胞变体——一种罕见实体。
Acta Endocrinol (Buchar). 2024 Apr-Jun;20(2):247-248. doi: 10.4183/aeb.2024.247. Epub 2025 Jan 18.
5
Genetic landscape of 482 thyroid carcinomas: analysis with the national datacenter for cancer genomic medicine in Japan.482 例甲状腺癌的基因组图谱:日本癌症基因组医学国家数据中心的分析。
Endocrine. 2024 Aug;85(2):766-776. doi: 10.1007/s12020-024-03738-y. Epub 2024 Feb 26.
6
A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.神经内分泌肿瘤综述:临床表现、病理生理学与管理
J Clin Med. 2023 Aug 5;12(15):5138. doi: 10.3390/jcm12155138.
7
RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report.地中海地区甲状腺髓样癌患者的RET原癌基因变异:简要报告
Life (Basel). 2023 Jun 6;13(6):1332. doi: 10.3390/life13061332.
8
Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature.包裹性甲状腺髓样癌的预后是否更好?一项病例系列研究及文献复习
Front Endocrinol (Lausanne). 2022 Apr 27;13:866572. doi: 10.3389/fendo.2022.866572. eCollection 2022.
9
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.
散发性大甲状腺髓样癌:淋巴结受累的预测因素
Virchows Arch. 2018 Mar;472(3):461-468. doi: 10.1007/s00428-018-2303-7. Epub 2018 Feb 1.
4
Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in Tumors.多组学数据在甲状腺髓样癌中的研究鉴定出 STAT3 通路是肿瘤潜在的治疗靶点。
Clin Cancer Res. 2017 Mar 1;23(5):1334-1345. doi: 10.1158/1078-0432.CCR-16-0947. Epub 2016 Sep 12.
5
Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.甲状腺髓样癌:包括微小RNA表达在内的最新进展
Endocr Pathol. 2016 Dec;27(4):312-324. doi: 10.1007/s12022-016-9449-0.
6
Histopathology of C Cells and Medullary Thyroid Carcinoma.C细胞与甲状腺髓样癌的组织病理学
Recent Results Cancer Res. 2015;204:41-60. doi: 10.1007/978-3-319-22542-5_2.
7
Revising the embryonic origin of thyroid C cells in mice and humans.修正小鼠和人类甲状腺C细胞的胚胎起源。
Development. 2015 Oct 15;142(20):3519-28. doi: 10.1242/dev.126581. Epub 2015 Sep 22.
8
RAS proto-oncogene in medullary thyroid carcinoma.甲状腺髓样癌中的RAS原癌基因。
Endocr Relat Cancer. 2015 Oct;22(5):R235-52. doi: 10.1530/ERC-15-0070.
9
C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.C细胞及其相关病变与病症:病理学家的观点
Turk Patoloji Derg. 2015;31 Suppl 1:60-79. doi: 10.5146/tjpath.2015.01315.
10
Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.遗传性和散发性甲状腺髓样癌的分子病理学
Am J Clin Pathol. 2015 Jun;143(6):768-77. doi: 10.1309/AJCPHWACTTUYJ7DD.